D M Goldenberg
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 36
- Radiopharmaceutical Chemistry and Applications 35
- Medical Imaging Techniques and Applications 8
-
- Glycosylation and Glycoproteins Research 19
- Co-authors
- F. James Primus (8 shared papers)R M Sharkey (10 shared papers)F. H. DeLand (3 shared papers)Sidney Bennett (3 shared papers)Robert M. Sharkey (14 shared papers)H. J. Hansen (9 shared papers)Rosalyn D. Blumenthal (6 shared papers)M. Jules Mattes (4 shared papers)
- Journals
- Cancer Research (6 papers)Journal of Clinical Oncology (6 papers)Proceedings of the National Academy of Sciences (4 papers)Chemotherapy (3 papers)JNCI Journal of the National Cancer Institute (3 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
D M Goldenberg
82 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 89
- Radiology, Nuclear Medicine and Imaging 1.5k
- Oncology 628
- Immunology 286
- Biotechnology 116
- Pathology and Forensic Medicine 205
Countries citing papers authored by D M Goldenberg
This map shows the geographic impact of D M Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D M Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D M Goldenberg more than expected).
Fields of papers citing papers by D M Goldenberg
This network shows the impact of papers produced by D M Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D M Goldenberg. The network helps show where D M Goldenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside D M Goldenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. | 1980 | 231 |
| 2 | 1981 | 109 | |
| 3 | 1996 | 105 | |
| 4 | Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts. | 1990 | 101 |
| 5 | Two new monoclonal antibodies, EPB-1 and EPB-2, reactive with human lymphoma. | 1989 | 79 |
| 6 | Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen. | 1988 | 73 |
| 7 | Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. | 1980 | 66 |
| 8 | Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. | 1987 | 57 |
| 9 | Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. | 1996 | 55 |
| 10 | Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody. | 1990 | 55 |
| 11 | Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. | 1990 | 54 |
| 12 | 2020 | 52 | |
| 13 | 1982 | 50 | |
| 14 | Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting. | 1990 | 49 |
| 15 | 1989 | 46 | |
| 16 | Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments. | 2000 | 46 |
| 17 | Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium. | 2001 | 46 |
| 18 | 1982 | 44 | |
| 19 | 1981 | 43 | |
| 20 | 2005 | 42 |
About D M Goldenberg
D M Goldenberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 86 papers that have together received 2.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (36 papers), Radiopharmaceutical Chemistry and Applications (35 papers), Glycosylation and Glycoproteins Research (19 papers), Cancer Research and Treatments (14 papers), Medical Imaging Techniques and Applications (8 papers), Medical Imaging and Pathology Studies (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.5k citations), Oncology (628 citations), Immunology (286 citations), Biotechnology (116 citations) and Pathology and Forensic Medicine (205 citations). D M Goldenberg has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include F. James Primus, R M Sharkey, F. H. DeLand, Sidney Bennett, Robert M. Sharkey, H. J. Hansen, Rosalyn D. Blumenthal, M. Jules Mattes, Thomas M. Behr and Arnold S. Dion. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Chemotherapy and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.